NEW YORK (GenomeWeb News) – Cell Signaling Technology today said that it will collaborate with TTP LabTech on developing antibody-based assays for high-content cellular analysis.
 
Danvers, Mass.-based CST intends to use its rabbit monoclonal antibody technology in developing and optimizing a catalog of high-content assays for cellular pathway profiling on TTP LabTech’s Acumen Explorer/eX3 platform. CST said that it will sell the assays to the drug discovery market and also offer them in its profiling services.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.